Plaque Modification Devices Market Report 2025

This Plaque Modification Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The plaque modification devices market size has grown strongly in recent years. It will grow from $1.38 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth during the historic period can be attributed to factors such as the increasing number of individuals suffering from cardiovascular and related diseases, a growing demand for minimally invasive procedures, an expanding geriatric population, a rise in atherosclerosis conditions, and a higher incidence of obesity among the population.

The plaque modification devices market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth during the forecast period can be attributed to factors such as the increasing number of minimally invasive procedures, a growing patient population with coronary issues, an aging population, favorable reimbursement policies, and the rising prevalence of sedentary lifestyles and related disorders. Key trends expected in the forecast period include the wider adoption of minimally invasive surgeries, the development and launch of new atherectomy devices, advancements in technology, investments in the creation of more accurate and innovative plaque modification devices, and the integration of new technologies.

The increasing number of minimally invasive procedures is anticipated to drive the growth of the plaque modification devices market in the future. Minimally invasive procedures are medical or surgical methods that involve smaller incisions, less disruption to tissues, and reduced physical trauma when compared to traditional open surgery. The rise in such procedures is fueled by technological advancements such as high-definition imaging and robotic systems, which enhance precision, as well as growing patient preferences for quicker recovery and less scarring. Plaque modification devices contribute to the safety and efficiency of minimally invasive procedures by enabling accurate removal of arterial blockages and expanding treatment options for patients with complex vascular conditions. For example, in January 2024, Intuitive Surgical Inc., a US-based company specializing in robotic products, reported the placement of 415 da Vinci surgical systems (robotic systems that utilize minimally invasive techniques) in the fourth quarter of 2023, marking a 12% increase from 2022. Thus, the growth in minimally invasive procedures is fueling the expansion of the plaque modification devices market.

Leading companies in the plaque modification devices market are focusing on creating advanced solutions, including intravascular image-guided, catheter-based systems, to maintain a competitive advantage. Intravascular image-guided procedures use imaging technology to assist in guiding devices or instruments within blood vessels. For example, in August 2024, Avinger, a US-based medical device company, introduced the Pantheris LV image-guided directional atherectomy system, designed to treat peripheral artery disease (PAD) in larger vessels such as the superficial femoral and popliteal arteries. This system features unique capabilities such as faster plaque excision for efficient removal of obstructive tissue, a proprietary jog mechanism that improves plaque apposition, and an advanced guidewire management system to simplify the operation process.

In May 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Shockwave Medical Inc. for an undisclosed sum. This acquisition aims to strengthen Johnson & Johnson's cardiovascular portfolio by incorporating Shockwave's intravascular lithotripsy technology, which is designed to treat calcified arterial plaque. The company anticipates this move will generate at least $1 billion in annual sales and help address gaps in the treatment of coronary and peripheral artery diseases. Shockwave Medical Inc., also based in the US, specializes in developing and commercializing medical products for cardiovascular conditions, including plaque modification devices.

Major players in the plaque modification devices market are Cardinal Health, Johnson & Johnson, Abbott Laboratories, Siemens Healthineers, Philips Healthcare, Becton Dickinson, Stryker Corporation, Boston Scientific, Terumo Corporation, Edward Lifesciences Corporation, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, Cardiovascular Systems Inc. (CSI), ACIST Medical Systems Inc., Endologix Inc., Avinger Inc., and SoundBite Medical Solutions Inc.

North America was the largest region in the plaque modification devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in plaque modification devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the plaque modification devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Plaque modification devices are medical tools and technologies designed to address atherosclerotic plaque accumulation in blood vessels. These devices are used in minimally invasive procedures to restore blood flow by removing, modifying, or managing plaque within the arteries, especially in cases of cardiovascular or peripheral artery diseases.

The primary types of plaque modification devices include atherectomy devices, thrombectomy devices, chronic total occlusion devices, and embolic protection devices. Atherectomy devices are specialized tools used to remove or reduce atherosclerotic plaque buildup in blood vessels, thus improving blood circulation. These devices are used to treat conditions such as coronary artery disease, peripheral artery disease, and neurovascular diseases, and are employed in various settings such as hospitals, ambulatory surgical centers, and other healthcare facilities.

The plaque modification devices market research report is one of a series of new reports that provides plaque modification devices market statistics, including plaque modification devices industry global market size, regional shares, competitors with a plaque modification devices market share, detailed plaque modification devices market segments, market trends and opportunities, and any further data you may need to thrive in the plaque modification devices industry. This plaque modification devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plaque modification devices market consists of sales of atherectomy devices, scoring balloons, cutting balloons, plaque excision systems, and rotational ablation devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.